OrthOmega 820 - 180 CT

OrthOmega 820 - 180 CT by Ortho Molecular Products

OrthOmega 820 - 180 CT is a cardiovascular health supplement by Ortho Molecular Products that contains highly concentrated oil derived from fish on the Chilean coast.* As such, it may be one of the cleanest and most sustainable sources of fish oil available in the world.*

Who Can Take OrthOmega 820 - 180 CT by Ortho Molecular Products?

OrthOmega 820 - 180 CT may support your health if you:

• suffer from cardiovascular disease (CVD)*
• may experience arrhythmia*
• have a high risk of suffering from Alzheimer’s disease and dementia*
• your diet does not include natural fish oil sources*

OrthOmega 820 - 180 CT—Potential Effects

OrthOmega 820 - 180 CT may affect your health by:

• supporting your blood sugar metabolism*
• managing cognitive function*
• supporting eye health*
• improving your skin, joints, and connective tissue health*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation at Covenant Health Products to learn more about OrthOmega 820 - 180 CT or our other supplements.

Recommendation:
Ortho Molecular Products suggest taking 1 OrthOmega 820 soft gel capsule per day, or as directed by your healthcare professional.

Serving Size: 1 Soft Gel Capsule
Servings Per Container: 180

Amount Per Serving:
Calories 15
Total fat 1.5 g
Cholesterol <5 mg
Total Omega-3s (as Triglycerides) 950 mg
EPA (Eicosapentaenoic Acid) 430 mg
DHA (Docosahexaenoic Acid) 390 mg
Omega-3s (additional) 130 mg
DPA (Docosapentaenoic acid) 50 mg

Other Ingredients: Highly Refined and Concentrated Omega-3 Fish Oil (anchovy), Capsule Shell (gelatin, glycerin, purified water), Natural Lemon/Lime Flavor, and a Proprietary Antioxidant Blend (consisting of natural tocopherols, rosemary extract, and ascorbyl palmitate).

Does Not Contain: Wheat, gluten, dairy, peanuts, tree nuts, egg, artificial colors, sweeteners or preservatives.

Cautions: If you are pregnant or nursing, consult your physician before taking this product.

Click here to view Product Info Sheet

References:

1. Connor, W. E. (2000). Importance of n-3 fatty acids in health and disease. American Journal of Clinical Nutrition, 71(1 Suppl), 171S-175S. https://doi.org/10.1093/ajcn/71.1.171S
2. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. (n.d.). Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico.
3. Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), 137-141. https://doi.org/10.1016/j.plefa.2010.06.001
4. Frangou, S., Lewis, M., & McCrone, P. (2006). Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. British Journal of Psychiatry, 188, 46-50. https://doi.org/10.1192/bjp.bp.105.015255
5. Jacques, C., Levy, E., Muckle, G., Jacobson, S. W., Bastien, C., Dewailly, E., Ayotte, P., Jacobson, J. L., & Saint-Amour, D. J. (2011). Long-term effects of prenatal omega-3 fatty acid intake on visual function in school-age children. Pediatrics, 158(1), 83-90, 90.e1. https://doi.org/10.1016/j.peds.2011.01.028
6. Kim, H. P., Mani, I., Iversen, L., & Ziboh, V. A. (1998). Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea pigs. Prostaglandins, Leukotrienes and Essential Fatty Acids, 58, 17-24. https://doi.org/10.1016/S0952-3278(98)90037-5
7. Montgomery, P., Burton, J. R., Sewell, R. P., Spreckelsen, T. F., & Richardson, A. J. (2013). Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: A cross-sectional analysis from the DOLAB Study. PLoS ONE, 8(6), e66697. https://doi.org/10.1371/journal.pone.0066697
8. Morris, M. C., Sacks, F., & Rosner, B. (1993). Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation, 88(2), 523-533. https://doi.org/10.1161/01.CIR.88.2.523
9. Nettleton, J. A., & Katz, R. (2005). n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review. Journal of the American Dietetic Association, 105(3), 428-440. https://doi.org/10.1016/j.jada.2004.12.018
10. Roche, H. M., & Gibney, M. J. (2000). Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. American Journal of Clinical Nutrition, 71(1 Suppl), 232S-237S. https://doi.org/10.1093/ajcn/71.1.232S
11. Yang, L. Y., Kuksis, A., & Myher, J. J. (1990). Lipolysis of menhaden oil triacylglycerols and the corresponding fatty acid alkyl esters by pancreatic lipase in vitro: A reexamination. Journal of Lipid Research, 31(1), 137-147.
12. Augood, C., Chakravarthy, U., Young, I., Vioque, J., de Jong, P. T., Bentham, G., Rahu, M., Seland, J., Soubrane, G., Tomazzoli, L., Topouzis, F., Vingerling, J. R., & Fletcher, A. E. (2008). Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. American Journal of Clinical Nutrition, 88(2), 398-406. https://doi.org/10.1093/ajcn/88.2.398
13. http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/HealthyDietGoals/Fish-and-Omega-3-Fatty-Acids_UCM_303248_Article.jsp
14. http://umm.edu/health/medical/altmed/supplement/omega3-fatty-acids